Founded
Address
Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States
Phone
Website
Recent investment activity
KANDO id: 30096
Corporate information
Registration country
Funding rounds
Actual initial investment stage
N/A (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 36| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Bayhill Therapeutics | A biopharmaceutical company focused on the translation of research into therapeutics for the treatment of autoimmune diseases. | N/A | |||
|
|
Cabrellis Pharmaceuticals Corp | Development of important therapies for the treatment of cancer | Series A | |||
|
|
Cerulean Pharma Inc | Series D | ||||
|
|
Cerulean Pharma Inc | Series C | ||||
|
|
CGI Pharmaceuticals Inc | A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. | N/A | |||
|
|
Conforma Therapeutics Corp | Novel drugs company for the selective treatment of cancer. | N/A | |||
|
|
Forma Therapeutics Inc | N/A | ||||
|
|
GlobeImmune Inc | Biopharmaceuticals company. | N/A | |||
|
|
Hydra Biosciences Inc | N/A | ||||
|
InCube Ventures LLC | Life science venture capital firm focused on investing in extraordinary innovations that solve unmet clinical needs for large patient populations. | N/A | |||
|
|
Intradigm Corp | N/A | ||||
|
|
IRX Therapeutics Inc | N/A | ||||
|
|
Kanisa Pharmaceuticals Inc | Biopharmaceutical company employing a targeted approach to the diagnosis and treatment of cancer. | N/A | |||
|
|
Nimbus Discovery LLC | A computational technology-based drug discovery company. | Series A | |||
|
|
Receptos Inc [] | Series A | ||||
|
|
RelayHealth Corp | N/A | ||||
|
|
Remon Medical Technologies Inc | Medical device company providing smart, miniature implants. | Series C | |||
|
|
Serenex Inc | Oncology-focused drug development company | N/A | |||
|
|
Sutro Biopharma Inc | Series C | ||||
|
|
Viamet Pharmaceuticals Inc | N/A | ||||
|
|
Aileron Therapeutics Inc | Developing a breakthrough proprietary peptide technology platform | N/A | |||
|
|
Anthera Pharmaceuticals Inc | N/A | ||||
|
|
Avid Radiopharmaceuticals Inc | Series D | ||||
|
|
Avid Radiopharmaceuticals Inc | Series C | ||||
|
|
Avid Radiopharmaceuticals Inc | Series A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| S Edward Torres | [email protected] |